At stake, the bill’s backers argued, is whether a rival will dominate another field the US pioneered, amid fears China could engineer bioweapons or otherwise capitalize on biological data vacuumed up from the rest of the world. Representative Brad Wenstrup, an Ohio Republican and the bill’s primary sponsor, said the companies were named because they are aligned with the Chinese Communist Party, which is intent on dominating the biotech industry, and said millions of Americans’ data is potentially at risk.
Read the article.
